Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXP vs MRNA✓SelectedUSD · MRNAAXP vs MRNA performance historyLatest closeAs of-1.36%11/19
Stock and ETF performance explorer

AXP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+224.0%
MRNA return
+806.0%
Excess return
-582.1%
Maximum drawdown
-49.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.4%+1.3%-2.7%-1.4%
7D-2.2%-13.8%+11.7%-1.9%
30D-2.3%-17.7%+15.4%-1.9%
3M-8.2%+14.3%-22.5%-8.7%
6M+1.2%+336.0%-334.8%-4.6%
YTD-15.0%+575.9%-590.9%-21.1%
1Y-8.7%+724.4%-733.1%-15.9%
3Y+98.0%+160.8%-62.8%+85.0%
5Y+90.6%-24.4%+115.1%+75.5%
All+224.0%+806.0%-582.1%+226.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling